Loading…
Arclin will expand methylamine production capacity by 35% and DMF capacity by 100% at its Belle, West Virginia facility. Asset installation begins in 2025, with all new capacities expected operational by end of 2026.
“This investment speaks to Arclin's excitement and commitment to the methylamines and derivatives business.”arclin.com
Summarized from public sources; check the original articles before acting on it.